SecBot SecBot
8-K ·Filed Jul 24, 2026

HCA

HCA Healthcare, Inc.
MIXED
Impact 5/10
Horizondays Processed3mo ago SEC0001193125-26-315151
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

Results were pre-released on July 14, so the confirmation is unlikely to move the stock significantly. The key tension is between volume growth (+2.5% admissions) and margin compression from payer mix deterioration. Watch the earnings call for commentary on exchange enrollment trends and the sustainability of Medicaid supplemental payments. The sharp drop in operating cash flow (-44%) and rising accounts receivable ($12.281B vs $10.867B at Dec 2025) warrant monitoring.

DirectionMixed
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$382.19
T+0 close · Jul 24, 2026 · via day close
Latest settled
+19.02%
T+60 · $454.88
Vs SPY
+15.73%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 24 $382.19entry
  2. T+1 · 4mo ago +1.94%α +1.92% · $389.62
  3. T+5 · 4mo ago +3.56%α +3.18% · $395.79
  4. T+20 · 3mo ago +12.30%α +8.67% · $429.19
  5. T+60 · 29d ago +19.02%α +15.73% · $454.88
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

HCA Healthcare reported Q2 2026 results consistent with its July 14 preview: revenue of $20.230B (+8.7% YoY) and GAAP EPS of $7.62 (+11.6% YoY), a 1.6% beat vs consensus of $7.50. However, the quarter was marked by a $400M unfavorable payer mix shift from health insurance exchange losses, partially offset by $400M in incremental Medicaid Supplemental Payment Program benefits. Full-year 2026 guidance was revised downward on net income and EPS, reflecting ongoing exchange-related headwinds. Operating cash flow fell sharply to $2.335B from $4.210B a year ago.

Key Financial Metrics

EPS
$7.62
est $7.50 · +1.6%
Revenue
$20.2B
est $19.7B · +2.5% · +8.7% YoY
Rating
in line
Guidance
$77.000B to $79.500B
lowered

Key Facts

  • Q2 2026 revenue $20.230B vs $18.605B YoY (+8.7%)
  • GAAP diluted EPS $7.62 vs $6.83 YoY (+11.6%), beating consensus $7.50 by 1.6%
  • Adjusted EBITDA $4.027B vs $3.849B YoY (+4.6%); margin contracted to 19.9% from 20.7%
  • Payer mix shift from health insurance exchanges had ~$400M unfavorable impact on pre-tax income
  • Incremental net benefit from Medicaid Supplemental Payment Programs of ~$400M in Q2
  • Full-year 2026 guidance revised: net income $6.300-$6.700B (from $6.495-$7.035B), EPS $28.70-$30.50 (from $29.10-$31.50)
  • Operating cash flow $2.335B in Q2 vs $4.210B in Q2 2025 (-44.5%)
  • Repurchased 4.752M shares for $2.064B in Q2; $7.210B remaining under authorization
  • Quarterly dividend declared at $0.78/share, payable Sept 30, 2026
  • Same facility admissions +2.5%, same facility equivalent admissions +2.7%, ER visits +3.6%

Financial Impact

Q2 revenue beat consensus by ~$490M (2.5%); EPS beat by $0.12 (1.6%). Full-year net income guidance midpoint lowered by ~$265M (3.9%).

revenueepsnet incomeadjusted EBITDAoperating cash flow

Risk Factors

  • Expiration of enhanced premium tax credits at end of 2025 could worsen exchange-related payer mix headwinds in 2027
  • Operating cash flow decline of 44% YoY raises questions about working capital management
  • Guidance lowered on net income and EPS despite revenue range being narrowed upward
  • Surgical volume declining (inpatient -2.3%, outpatient -3.4%) signals potential service mix shift away from higher-revenue procedures
  • Total debt of $49.718B vs stockholders' deficit of $6.642B; leverage remains elevated

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
63% bullish (30 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-315151
Document: hca-20260724.htm0001193125-26-315151
Document: 0001193125-26-315151-index-headers.html0001193125-26-315151
Document: 0001193125-26-315151-index.html0001193125-26-315151
Document: 0001193125-26-315151.txt0001193125-26-315151
8-K Data (Synthetic)0001193125-26-315151

US Market Status

Market Closed · Opens in 7h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 24, 2026